Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Theranos Founder Holmes, President Balwani Indicted

Published: Fri, 15 Jun 2018 21:22:27 EDT
Theranos Inc founder Elizabeth Holmes and the blood testing company’s former president, Ramesh 'Sunny' Balwani, have been indicted by a federal grand jury in California on charges of wire fraud, the US Justice Department said on Friday.
Reuters Health Information

Investigational Oral Medication Promising for Endometriosis Pain

Published: Fri, 15 Jun 2018 18:05:33 EDT
Investigational oral agent, elagolix, shows promise for the treatment of endometriosis-related pain with good efficacy and safety data now out to 12 months in 2 extension studies; drug is awaiting approval.
Medscape Medical News

NSAIDs Increase Cardiovascular Risk in Osteoarthritis

Published: Fri, 15 Jun 2018 16:46:44 EDT
Nonsteroidal anti-inflammatory drugs contribute to the elevated risk for cardiovascular disease in people with osteoarthritis, new research shows, but alternatives for pain management are limited.
Medscape Medical News

Fourth EAN Meeting Tackles Theme of Neurogenetics

Published: Fri, 15 Jun 2018 16:45:10 EDT
New insights into genetic influences on brain disorders are emerging every day, says the president of the European Academy of Neurology.
Medscape Medical News
Displaying results 17-20 (of 20)
 1 - 2 - 3 - 4 - 5 


Galmed’s stock soars after phase 2 NASH results

Published: Tue, 12 Jun 2018 13:41:52 +0000
Galmed Pharmaceuticals unveiled top-line results from a yearlong phase 2b study of its oral treatment for nonalcoholic steatohepatitis, demonstrating a statistically significant reduction in liver fat without worsening fibrosis.

Targovax tumbles after chemotherapy cocktail data dent pancreatic cancer plans

Published: Tue, 12 Jun 2018 12:35:32 +0000
Targovax has hit pause on its neoantigen vaccine R&D strategy after seeing independent data that will redefine the standard of care in resected pancreatic cancer. The leap forward in the treatment of the disease forced Targovax to rethink its strategy and pull out of a planned phase 2 trial.

Consolidate pRED and gRED R&D units? ‘No way,’ says Roche CEO

Published: Tue, 12 Jun 2018 12:06:00 +0000
Like just about all its peers in the pharma sector, Roche has been trying to find ways to reduce the costs of R&D—but CEO Severin Schwann won’t contemplate doing so by consolidating its Swiss-led research operations with those of subsidiary Genentech.

Lilly, AstraZeneca halt phase 3 Alzheimer’s trials for futility, further denting BACE prospects

Published: Tue, 12 Jun 2018 09:03:01 +0000
Eli Lilly and AstraZeneca have pulled the plug on two phase 3 trials of BACE inhibitor lanabecestat in Alzheimer’s disease. The partners stopped the studies after an independent interim analysis deemed they were destined to fail.
Displaying results 17-20 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy